Steven Cohen’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.68M Buy
+85,000
New +$5.91M 0.01% 1613
2026
Q2
– Sell
-226,251
Closed -$15.9M – 4573
2026
Q1
$15.9M Buy
226,251
+188,623
+501% +$13.2M 0.02% 941
2025
Q4
$3.08M Buy
+37,628
New +$2.81M ﹤0.01% 2187
2024
Q1
– Sell
-19,575
Closed -$396K – 2604
2023
Q4
$396K Sell
19,575
-79,725
-80% -$1.33M ﹤0.01% 1642
2023
Q3
$1.76M Buy
+99,300
New +$1.76M 0.01% 1174

Other funds holding TARS

Steven Cohen's TARS Position: Q3 2026 in Review

Steven Cohen opened a new position in Tarsus Pharmaceuticals (TARS) in Q3 2026: 85,000 shares worth $6.68M. The stake represents 0.01% of the portfolio and ranks #1613 among its holdings. This is a return to the name: Steven Cohen previously reported a position in TARS as recently as Q1 2026.

Steven Cohen first reported a position in TARS in Q3 2023 and has held it in 5 quarters since. The position peaked at $15.9M in Q1 2026. 254 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Steven Cohen held 85,000 shares of Tarsus Pharmaceuticals worth $6.68M as of Q3 2026.
  • Tarsus Pharmaceuticals was a new Steven Cohen position in Q3 2026.
  • Tarsus Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1613 holding.
  • Steven Cohen first reported a position in Tarsus Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
  • Steven Cohen's Tarsus Pharmaceuticals position peaked at $15.9M in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.